Table 2.

Association of the total, first- and second-phase area under the curve (AUC) GLP-1/PG, AUC GLP-1/Ins, and Ins/PG ratios with post-GDM status after adjustment for age and BMI

	OR	95% CI	P value
GLP-1/PG
AUC total GLP/PG	0.940	(0.895 to 0.981)	0.0078
AUC 0–30 GLP/PG	0.850	(0.635 to 1.138)	0.2702
AUC 30–120 GLP/PG	0.928	(0.877 to 0.974)	0.0052
GLP-1/Ins
AUC total GLP/insulin	0.984	(0.971 to 0.997)	0.0155
AUC 0–30 GLP/insulin	0.999	(0.635 to 1.138)	0.2702
AUC 30–120 GLP/insulin	0.972	(0.953 to 0.989)	0.0025
Ins/PG
AUC total insulin/PG	1.012	(0.996 to 1.031)	0.1727
AUC 0–30 insulin/PG	0.995	(0.899 to 1.108)	0.9194
AUC 30–120 insulin/PG	1.015	(0.997 to 1.037)	0.1392

OR and 95% CI for post-GDM were calculated based on multivariate logistic regression models adjusted for age and BMI (n=196).

AUC, area under the curve; BMI, body mass index; GDM, gestational diabetes mellitus; GLP-1, glucagon-like peptide-1; Ins, plasma insulin; OGTT, oral glucose tolerance test; PG, plasma glucose.